From July 1, 2022 to September 30, 2022, the company has repurchased 3,361,740 shares, representing 1.17% for $697.52 million. With this, the company has completed the repurchase of 21,624,430 shares, representing 7.24% for $4,895.91 million under the buyback announced on January 27, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
319.4 USD | +2.94% | +1.76% | +18.01% |
Apr. 22 | Mizuho Adjusts Price Target on HCA Healthcare to $370 From $345 | MT |
Apr. 22 | Ondine Biomedical celebrates use of Steriwave in Australian hospital | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.01% | 82.08B | |
-13.25% | 87.77B | |
+11.97% | 30.03B | |
-8.50% | 17.08B | |
-1.46% | 16.41B | |
+4.44% | 12.37B | |
+5.11% | 12.17B | |
-31.05% | 11.89B | |
+27.83% | 11.62B | |
+8.18% | 10.85B |
- Stock Market
- Equities
- HCA Stock
- News HCA Healthcare, Inc.
- Tranche Update on HCA Healthcare, Inc.'s Equity Buyback Plan announced on January 27, 2022.